Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Haematology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Grade 3/4 AEs ‐ overall analysis · newly diagnosed or relapsed patients with CLL

The intervention probably leads to higher grade 3/4 AEs ‐ overall analysis (moderate certainty).

1 finding from 1 review

Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia 2012 · Cochrane Headline outcomes only
RR 1.15 [1.08, 1.23]
3 studies · 1398 participants
Moderate